SXI Life Sciences
7.554,07
PKT
+3,66
PKT
+0,05
%
Werbung
Analysen zu SXI Life Sciences-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 16.01.13 | Novartis halten | Hamburger Sparkasse AG (Haspa) | |
| 14.01.13 | Novartis verkaufen | Vontobel Research | |
| 11.01.13 | Novartis verkaufen | Vontobel Research | |
| 10.01.13 | Novartis halten | Independent Research GmbH | |
| 08.01.13 | Lonza halten | Vontobel Research | |
| 04.01.13 | Straumann halten | Vontobel Research | |
| 19.12.12 | Lonza hold | Vontobel Research | |
| 17.12.12 | Lonza hold | Vontobel Research | |
| 13.12.12 | Novartis hold | Deutsche Bank AG | |
| 12.12.12 | Novartis outperform | Credit Suisse Group | |
| 11.12.12 | Tecan (N) buy | UBS AG | |
| 11.12.12 | Novartis halten | Norddeutsche Landesbank (Nord/LB) | |
| 11.12.12 | Novartis reduce | Vontobel Research | |
| 10.12.12 | Straumann kaufen | Die Actien-Börse | |
| 10.12.12 | Novartis neutral | J.P. Morgan Cazenove | |
| 10.12.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 10.12.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 04.12.12 | Sonova overweight | Morgan Stanley | |
| 30.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 29.11.12 | Lonza hold | Vontobel Research | |
| 27.11.12 | Novartis kaufen | Hamburger Sparkasse AG (Haspa) | |
| 26.11.12 | Straumann hold | Vontobel Research | |
| 26.11.12 | Lonza hold | Vontobel Research | |
| 26.11.12 | Straumann neutral | Sarasin Research | |
| 23.11.12 | Sonova kaufen | Fuchsbriefe | |
| 22.11.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 21.11.12 | Novartis reduce | Vontobel Research | |
| 20.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 20.11.12 | Novartis buy | Sarasin Research | |
| 16.11.12 | Novartis outperform | Exane-BNP Paribas SA | |
| 15.11.12 | Novartis buy | UBS AG | |
| 15.11.12 | Novartis outperform | Sanford C. Bernstein and Co., Inc. | |
| 14.11.12 | Sonova neutral | UBS AG | |
| 14.11.12 | Sonova overweight | J.P. Morgan Cazenove | |
| 14.11.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 14.11.12 | Sonova buy | Vontobel Research | |
| 13.11.12 | Sonova buy | Vontobel Research | |
| 13.11.12 | Sonova neutral | Sarasin Research | |
| 12.11.12 | Novartis outperform | Credit Suisse Group | |
| 12.11.12 | Sonova underperform | Exane-BNP Paribas SA |